Scientists developed an oral CRISPR–Cas9 delivery system based on zwitterionic and polysaccharide polymer-coated nanocomplexes that disrupted the tumor necrosis factor receptor-associated protein 1 gene in colorectal cancer.
[Nature Nanotechnology]
